Carlisle Companies Incorporated (CSL)

Total asset turnover

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Revenue US$ in thousands 5,003,600 4,586,900 6,591,900 4,810,300 3,969,900
Total assets US$ in thousands 5,816,600 6,620,000 7,222,000 7,246,800 5,866,400
Total asset turnover 0.86 0.69 0.91 0.66 0.68

December 31, 2024 calculation

Total asset turnover = Revenue ÷ Total assets
= $5,003,600K ÷ $5,816,600K
= 0.86

Based on the provided data, Carlisle Companies Incorporated's total asset turnover ratio has fluctuated over the past five years. The ratio was 0.68 as of December 31, 2020, declined to 0.66 by December 31, 2021, then saw a significant increase to 0.91 by December 31, 2022, before dropping back to 0.69 by December 31, 2023, and finally reaching 0.86 by December 31, 2024.

A total asset turnover ratio measures a company's ability to generate sales from its assets. A higher ratio generally indicates that the company is more efficient in using its assets to generate revenue. In Carlisle Companies Incorporated's case, the increase in the ratio from 2021 to 2022 suggests improved efficiency in utilizing its assets to generate revenue. However, the subsequent decrease in 2023 indicates a potential decline in this efficiency, although the ratio rebounded in 2024.

Overall, Carlisle Companies Incorporated should continue to monitor its total asset turnover ratio to ensure optimal utilization of its assets to drive sales and profitability.


Peer comparison

Dec 31, 2024

Company name
Symbol
Total asset turnover
Carlisle Companies Incorporated
CSL
0.86
West Pharmaceutical Services Inc
WST
0.79